Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Filings indexed 1,323 across all filing types
Latest filing 2022-03-25 Director's Dealing
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-03-25 English
FORM 4
Director's Dealing
2022-03-04 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes an Item 2.02 Results of Operations and Financial Condition, referencing a press release of financial results and a slide presentation for a conference call, but does not contain the financial results itself. It also includes Item 5.02 about departure of a director, which is a management change announcement. The document is short (4498 characters) and primarily announces events rather than providing detailed financial statements or full reports. Therefore, it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2022-02-17 English
10-K
Annual Report FY 2021
2022-02-17 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-14 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.